Fosun Pharmaceutical ready to make a bid for Stada

Reuters reported today, quoting people close to the matter, that Shanghai Fosun Pharmaceutical is about to place an offer for Stada, and possibly in Joint Venture with a buyout fund like CVC. Fosun Pharma is part of Fosun International, a conglomerate with a market capitalization exceeding €12bn, owned by billionaire Guo Guangchang. Guangchang has already announced he is determined to enter new markets, indeed the group acquired India-based Gland Pharma in 2016. (Source: Reuters)